|
|
|
|
Partnering with a CQA monitoring expert supports protein variant characterization and ensures biotherapeutic safety and efficacy. Uncover how a CDMO with deep expertise in CQA analytics, protein variants, and patient-focused development can help safeguard your product.
|
|
|
|
|
This presentation examines key challenges in biologics analysis, including molecular heterogeneity, aggregation, and stability, while showcasing a diverse range of advanced tools and innovative methods to improve biophysical analysis reliability and efficiency.
|
|
|
|
|
A new duplex RT-qPCR potency bioassay shows promise for evaluating relative transcription activity. Explore the strengths and limitations of transcriptional assays versus reporter gene assays, and how they compare to ddPCR and flow cytometry in cell and gene therapy analysis.
|
|
|
|
|
|
|
Learn how our expertise and advanced capabilities provide customized analytical solutions that ensure quality, precision, and regulatory compliance for your biotherapeutics.
|
|
|
